Anil Ambani led Reliance Infrastructure shares jump as shareholders approve Rs 6000 cr fundraising plan

Shares of Anil Ambani-led Reliance Infrastructure is in focus after shareholders overwhelmingly approved the company’s plan to raise Rs 6,000 crore through a Preferential Issue and Qualified Institutional Placement (QIP). The resolutions received over 98% of votes in favour during a postal ballot, signalling strong support for the move.

Reliance Infrastructure’s Preferential Issue Details

In the first phase, Reliance Infrastructure will launch a Rs 3,014 crore preferential issue, offering 12.56 crore equity shares or convertible warrants at Rs 240 per share. Promoters, through Risee Infinity, will contribute Rs 1,104 crore by subscribing to 4.60 crore shares.

Also ReadFIIs continue to pummel markets

Additionally, two other major investors—Mumbai-based Fortune Financial & Equities Services and Florintree Innovations LLP, led by former Blackstone executive Mathew Cyriac—will invest Rs 1,058 crore and Rs 852 crore, respectively. Together, they will acquire a total of 7.96 crore shares.

Also Read Stocks To Watch: HDFC Bank, Tech Mahindra, Kotak Mahindra, Jio Financial Services, MCX, Godrej Properties, Oberoi Realty, L&T Finance, RBL Bank, Bajaj Housing Finance Hyundai IPO GMP Allotment status Highlights: Latest information on GMP, allotment, listing, and price band Stock Market Highlights: Markets closes in red! Nifty below 24,800, Sensex holds 81,000; Bajaj Auto ends 13% down FIIs continue to pummel markets

Breakdown of Fundraising Plan

The board had initially approved the fund-raising plan on 19 September. Out of the total Rs 6,000 crore, Rs 3,014 crore will be raised through a preferential allotment of shares or convertible warrants, while the remaining Rs 3,000 crore is set to be raised via a QIP.

Manjari Kacker Joins as Independent Director

In addition to the fund-raising approvals, shareholders also voted in favor of appointing Manjari Kacker as an independent director. Her inclusion on the board is expected to enhance the company’s governance standards, adding valuable expertise to Reliance Infrastructure’s leadership team.

Strengthening Net Worth and Reducing Debt

The Preferential Issue is expected to enhance Reliance Infrastructure’s net worth from Rs 9,000 crore to Rs 12,000 crore, significantly improving the company’s financial health. The fund infusion will also help in reducing the company’s debt load, positioning it for stronger future growth.

Also ReadNSE raises minimum contract value for index derivatives

The proceeds from the fundraising will be directed towards expanding the company’s business operations,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth